PRGO - Perrigo Company plc

NYSE - NYSE Delayed Price. Currency in USD
60.43
-2.36 (-3.76%)
At close: 4:01PM EST

60.51 +0.09 (0.15%)
Pre-Market: 5:20AM EST

Stock chart is not supported by your current browser
Previous Close62.79
Open62.50
Bid60.54 x 100
Ask60.73 x 800
Day's Range60.38 - 63.10
52 Week Range60.38 - 95.93
Volume2,085,683
Avg. Volume1,488,438
Market Cap8.21B
Beta (3Y Monthly)0.68
PE Ratio (TTM)68.51
EPS (TTM)0.88
Earnings DateNov 7, 2018 - Nov 12, 2018
Forward Dividend & Yield0.76 (1.21%)
Ex-Dividend Date2018-11-29
1y Target Est74.67
Trade prices are not sourced from all markets
  • Thomson Reuters StreetEvents17 hours ago

    Edited Transcript of PRGO earnings conference call or presentation 8-Nov-18 1:30pm GMT

    Q3 2018 Perrigo Company PLC Earnings Call

  • David Einhorn's Top 4 Sells in 3rd Quarter
    GuruFocus.com5 days ago

    David Einhorn's Top 4 Sells in 3rd Quarter

    Top sells include Mylan and GM. Investor also axed Apple and Micron

  • GlobeNewswire8 days ago

    Sol-Gel Technologies Reports Third Quarter 2018 Financial Results

    NESS ZIONA, Israel, Nov. 13, 2018 -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying,.

  • GuruFocus.com9 days ago

    Weekly CEO Buys Highlight

    Details the CEO buys this past week for the following companies: New Media Investment, American Axle & Manufacturing, Perrigo, IBM and Cooper-Standard Holdings

  • GuruFocus.com10 days ago

    Stocks That Fell to 3-Year Lows in the Week of Nov. 9

    General Electric Co., Vodafone Group PLC, Ctrip.com International Ltd. and Perrigo Co. PLC have declined to their respective 3-year lows

  • Assessing GW Pharmaceuticals’ Year-to-Date Performance
    Market Realist12 days ago

    Assessing GW Pharmaceuticals’ Year-to-Date Performance

    GW Pharmaceuticals (GWPH) is a developer of plant-derived cannabinoid therapeutics. GW Pharmaceuticals reported EPS of -$1.26 on revenue of $3.46 million in the third quarter, reflecting a 10.2% year-over-year revenue rise in the quarter.

  • GuruFocus.com12 days ago

    Perrigo Co Plc (PRGO) CEO Murray S Kessler Bought $1 million of Shares

    CEO of Perrigo Co Plc (NYSE:PRGO) Murray S Kessler bought 15,683 shares of PRGO on 11/09/2018 at an average price of $63.79 a share.

  • ACCESSWIRE12 days ago

    Today’s Research Reports on Stocks to Watch: Perrigo Company and Novelion Therapeutics

    NEW YORK, NY / ACCESSWIRE / November 9, 2018 / While shares of healthcare company Perrigo Company were tanking after reporting third quarter financial results, Novelion Therapeutics, which is developing ...

  • Barrons.com12 days ago

    The Biggest Loser: Perrigo Tumbles 16%

    Perrigo lost $12.26, or 16.3%, to $62.88. Perrigo lowered its full-year guidance, as it now sees EPS between $4.45 and $4.65, down from $4.75 to $4.95, on revenue of $4.72 billion, down from $4.8 billion to $4.9 billion. Leerink’s Ami Fada reiterated a Market Perform rating on the stock, writing that “once again the top line continues to be weak and 2018 guidance was lowered primarily due to the prescription segment.” While this “shouldn’t be a complete surprise given prescription trends,” she expected the stock to be weak on the news.

  • GuruFocus.com13 days ago

    3 Stocks Move Thursday

    Financial results impact Herc Holdings, Perrigo and Roku

  • Reuters13 days ago

    US STOCKS-S&P 500 edges lower ahead of Fed decision

    The S&P 500 inched lower on Thursday, as disappointing results from a slew of companies, including Qualcomm Inc, countered gains in bank stocks ahead of the Federal Reserve's interest rate decision. Among the biggest decliners on the benchmark index were Perrigo Co, Wynn Resorts Ltd and D.R. Horton Inc, all falling on disappointing quarterly results.

  • Perrigo Company PLC (PRGO) Q3 2018 Earnings Conference Call Transcript
    Motley Fool13 days ago

    Perrigo Company PLC (PRGO) Q3 2018 Earnings Conference Call Transcript

    PRGO earnings call for the period ending September 29, 2018.

  • Barrons.com13 days ago

    Midday Movers: Perrigo Plunges, TripAdvisor Soars, Tesla Advances

    STOCKSTOWATCHTODAY BLOG One day after the Dow Jones Industrial Average rose more than 500 points, the Dow has advanced 55.40 points, or 0.2%, to 26,235.70, while the S&P 500 has dipped 0.1%, to 55.40, and the Nasdaq Composite has declined 0.

  • Reuters13 days ago

    US STOCKS-Weak results keep S&P, Nasdaq lower ahead of Fed decision

    The S&P 500 and the Nasdaq edged lower on Thursday, as weak earnings reports and caution ahead of the Federal Reserve's interest rate decision stalled a rally from the previous session, which was spurred by the outcome for midterm elections. Among the biggest deliners on the S&P 500 were Perrigo Co , Wynn Resorts Ltd and D.R. Horton Inc, all falling on disappointing quarterly results.

  • The Wall Street Journal13 days ago

    [$$] Perrigo Strikes Out Again

    Perrigo shares fell sharply after the report and are down nearly 30% so far this year. Perrigo said on the call that problems included an “absence of new products, price erosion in authorized generic products and customer-service challenges resulting in lower sales volumes.” Perrigo plans to sell or spin off the generics business, but it is hard to imagine a buyer will pay a good price to own what is clearly a troubled operation. Perrigo won’t provide financial guidance for 2019 until February, but another decline would mark three consecutive years of falling profits.

  • Simply Wall St.13 days ago

    Do Directors Own Perrigo Company plc (NYSE:PRGO) Shares?

    The big shareholder groups in Perrigo Company plc (NYSE:PRGO) have power over the company. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a Read More...

  • Perrigo (PRGO) Beats on Q3 Earnings, Cuts View, Shares Down
    Zacks13 days ago

    Perrigo (PRGO) Beats on Q3 Earnings, Cuts View, Shares Down

    Perrigo (PRGO) reports mixed third-quarter 2018 results and lowers revenue and adjusted earnings guidance for 2018 for the second straight quarter.

  • Reuters13 days ago

    US STOCKS-Wall St dips as weak earnings dampen surge from midterm elections

    U.S. stocks edged lower on Thursday, as a clutch of weak earnings reports punctured a rally from the previous session, which was spurred by the outcome for midterm elections. Wynn Resorts Ltd, Perrigo Co and D.R. Horton Inc were the biggest losers on the S&P 500, all falling after reporting disappointing quarterly results. Qualcomm Inc dropped 7.1 percent after the chipmaker forecast sales revenue for the holiday shopping quarter below analysts' estimates, as it took a hit from the loss of chip sales to Apple Inc.

  • Reuters13 days ago

    US STOCKS-Wall St set to open lower after election surge; Fed meet in focus

    U.S. stock indexes were set to dip on Thursday, following a rally in the previous session that was spurred by relief after the midterm elections, with investor focus shifting to the Federal Reserve's interest rate decision. Stocks gained more than 2 percent on Wednesday after Americans voted for a divided Congress, which was largely anticipated by investors who raised bets that it would be positive for stocks.

  • Perrigo (PRGO) Q3 Earnings Beat Estimates
    Zacks13 days ago

    Perrigo (PRGO) Q3 Earnings Beat Estimates

    Perrigo (PRGO) delivered earnings and revenue surprises of 3.81% and -3.23%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • CNBC13 days ago

    Stocks making the biggest move premarket: ARRS, COMM, PRGO, DHI, PRTY & more

    These are the stocks posting the largest moves before the bell.

  • Investopedia13 days ago

    10 Health Care Stocks Seen Jumping on Takeovers

    Mergers and acquisitions have been proceeding at a torrid pace, and the health care sector may be an especially active area for future consolidation. In the first half of 2018, the value of M&A deals hit all-time records both worldwide and in the U.S., up by 64% and 79%, respectively, from the first half of 2017, per data from Thomson Reuters cited by Axios.com. Per Business Insider, these are the top 10 takeover candidates that Morgan Stanley sees in the health care sector: IQVIA Holdings Inc. ( IQV), BioMarin Pharmaceutical Inc. ( BMRN), Seattle Genetics Inc. ( SGEN), DaVita Inc. ( DVA), Universal Health Services Inc. ( UHS), Dexcom Inc. ( DXCM), Neurocrine Biosciences Inc. ( NBIX), Perrigo Co. PLC ( PRGO), Nektar Therapeutics ( NKTR), and Sarepta Therapeutics  Inc. ( SRPT).

  • Associated Press13 days ago

    Perrigo: 3Q Earnings Snapshot

    On a per-share basis, the Dublin-based company said it had a loss of 49 cents. Earnings, adjusted for one-time gains and costs, came to $1.09 per share. The results beat Wall Street expectations. The average ...

  • Perrigo Company plc Reports Third Quarter 2018 Financial Results
    PR Newswire13 days ago

    Perrigo Company plc Reports Third Quarter 2018 Financial Results

    DUBLIN , Nov. 8, 2018 /PRNewswire/ -- Realized third quarter 2018 GAAP ("reported") net sales of $1.1 billion , reported net loss of $68 million compared to a net income of $45 million last year ...

  • Benzinga14 days ago

    Perrigo Q3 Earnings Preview

    Perrigo (NYSE: PRGO ) announces its next round of earnings this Thursday, Nov. 8. Here's Benzinga's advanced look at Perrigo's Q3 earnings report. Earnings and Revenue Wall Street analysts see Perrigo ...